biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
04:19 Broccoli compound helped lab worms live over 50% longer, study finds✦04:16 A one-time gut procedure limited weight regain after Zepbound, maker says✦04:10 FDA drafts a quicker path to approval for some custom gene therapies✦22:14 Researchers map how the cells lining blood vessels change with age✦22:14 Short voice recordings estimate a 'speech age' that runs older in dementia✦22:11 Biotech ends donor immune cell therapy for arthritis after 2 trial deaths✦22:11 17 blood proteins tied to death risk and faster aging in older adults✦16:11 Certain gut bacteria linked to slower or faster aging in 123 adults✦04:19 Broccoli compound helped lab worms live over 50% longer, study finds✦04:16 A one-time gut procedure limited weight regain after Zepbound, maker says✦04:10 FDA drafts a quicker path to approval for some custom gene therapies✦22:14 Researchers map how the cells lining blood vessels change with age✦22:14 Short voice recordings estimate a 'speech age' that runs older in dementia✦22:11 Biotech ends donor immune cell therapy for arthritis after 2 trial deaths✦22:11 17 blood proteins tied to death risk and faster aging in older adults✦16:11 Certain gut bacteria linked to slower or faster aging in 123 adults
← All story threadsSTORY THREAD

GSK's shot aiming to clear hepatitis B.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 20, 2026
    FDA APPROVES THE TREATMENTFDA approval · 1,838 adults

    FDA approves hepatitis B shots that let some patients stop all treatment

    The FDA has approved GSK's Hibsago, a six-month course of injections. In two large trials, about 1 in 5 people kept the virus in check after stopping all hepatitis B drugs.